Fecal Excretion Of Triglyceride Research Articles

Edible Red Seaweed Hypnea asiatica Ameliorates High-Fat Diet-Induced Metabolic Diseases in Mice.

Metabolic diseases, including obesity, diabetes, and fatty liver disease, are dramatically increasing around the world. Seaweed is low in calories and rich in many active ingredients that are necessary for maintaining good health, and is expected to be effective for preventing metabolic diseases. The purpose of this study was to examine the effects of a traditional Japanese edible seaweed Hypnea asiatica (H. asiatica) on obesity, using a mouse model. H. asiatica was dried and powdered, mixed with a high-fat diet, and fed to male C57BL/6J mice for 13 weeks. On the last day of the experiment, blood samples were collected under anesthesia and biochemical parameters such as lipids and adipokines were measured. Liver and adipose tissue were excised, weighed, and oxidant/antioxidant parameters were measured. Some mice were perfused with a fixative solution containing formalin, and tissue specimens were prepared. A glucose tolerance test was used to assess insulin resistance. The inhibition of lipase activity was evaluated in vitro. Thirteen-week supplementation with H. asiatica suppressed body weight gain, body fat accumulation, and blood glucose levels. H. asiatica also improved fatty liver and hypercholesterolemia, and reduced the oxidant and inflammatory parameters of serum and liver. H. asiatica increased fecal triglyceride excretion and polyphenol-rich ethanol extract of H. asiatica inhibited lipase activity in vitro. These results suggest that polysaccharides and polyphenols in H. asiatica may ameliorate obesity and diabetes by inhibiting intestinal fat absorption and reducing oxidative stress and inflammation. H. asiatica may be useful in preventing metabolic diseases such as obesity, diabetes, and fatty liver.

Dietary supplementation with okara and Bacillus coagulans lilac-01 improves hepatic lipid accumulation induced by cholic acids in rats

Cholic acid supplementation induced lipid accumulation in the liver and a reduction in iron concentration in rats. Dietary supplementation with okara, a by-product of tofu manufacturing from soybean, and Bacillus coagulans lilac-01, protects against leaky gut and lipid accumulation with reducing the expression of fatty acid synthase ( Fasn ) in the liver and enhancement of fecal triglyceride and non-12αhydroxylated bile acid excretion accompanied by an increase in cecal propionic acid concentration. • Okara and Bacillus coagulans lilac-01 is a dietary synbiotic (Syn) • Cholic acid (CA) induces lipid accumulation in rats in a 2-week study. • Syn ameliorates CA-induced hepatic lipid accumulation and leaky gut. • Syn enhances fecal excretion of triglyceride and non-12αhydroxylated bile acids. A dietary symbiotic supplement of okara, a by-product of tofu manufacturing with Bacillus coagulans lilac-01 found to reduce secondary bile acid (BA) in a rat study and cholic acid (CA), a primary 12α-hydroxylated (12αOH) BA, induces lipid accumulation in rats. In this study, we investigated whether dietary supplementation of a synbiotic with okara and Bacillus coagulans lilac-01 improves CA-induced hepatic lipid accumulation. Male Wistar/ST rats (4 weeks old) were fed with or without CA-supplementation combined with the synbiotic for 2 weeks. The CA diet increased hepatic triglycerides and the synbiotic diet in combination with CA normalized liver triglyceride concentration accompanied by suppression of hepatic fatty acid synthase expression, enhancement of fecal triglyceride excretion, and increase in fecal non-12αOH BA excretion. Dietary supplementation with the okara synbiotic ameliorated hepatic lipid accumulation probably by reducing de novo lipogenesis and enhancing fecal triglyceride excretion.

Molecular Mechanisms of the Anti-obesity Properties of Agardhiella subulata in Mice Fed a High-Fat Diet.

The overweight and obese population has skyrocketed, resulting in a high incidence of metabolic disorders. Agardhiella subulata (AS) contains a variety of beneficial components, such as sulfur-containing polysaccharides (dietary fiber) and astaxanthin, which is considered to have anti-obesity potential. In this study, we investigated the effects and possible mechanisms of dietary AS on high-fat diet (HFD)-induced obesity in mice. AS supplementation significantly reduced HFD-induced weight gain (19%) and the visceral adiposity index (4.1%). In addition, the level of total cholesterol, triglyceride, and low-density lipoprotein was significantly decreased; adiponectin was significantly increased in serum and fecal triglyceride excretion was significantly higher in mice fed AS compared with mice on an HFD. Preadipocyte factor 1 and Sry-box transcription factor 9 that were significantly higher than the levels found for the HFD group lead to reduced adipogenesis. Moreover, accompanying the lipolysis and fatty acid β-oxidation that occur in the AS group, the concentration of non-esterified fatty acids was lowered to 0.4 ± 0.1 mEq/L. In addition, peroxisome proliferator-activated receptor γ and phosphorylation acetyl-CoA carboxylase increased 1.5- and 1-fold, thus increasing the expression of adiponectin and the activation of AMPK and ultimately resulting in lower blood glucose levels. The results of this study suggest that AS supplementation increases lipid excretion and improves energy metabolism to prevent obesity in mice fed a HFD.

The Edible Brown Seaweed Sargassum horneri (Turner) C. Agardh Ameliorates High-Fat Diet-Induced Obesity, Diabetes, and Hepatic Steatosis in Mice.

Sargassum horneri (Turner) C. Agardh (S. horneri) is edible brown seaweed that grows along the coast of East Asia and has been traditionally used as a folk medicine and a local food. In this study, we evaluated the effects of S. horneri on the development of obesity and related metabolic disorders in C57BL/6J mice fed a high-fat diet. S. horneri was freeze-dried, fine-powdered, and mixed with a high-fat diet at a weight ratio of 2% or 6%. Feeding a high-fat diet to mice for 13 weeks induced obesity, diabetes, hepatic steatosis, and hypercholesterolemia. Supplementation of mice with S. horneri suppressed high-fat diet-induced body weight gain and the accumulation of fat in adipose tissue and liver, and the elevation of the serum glucose level. In addition, S. horneri improved insulin resistance. An analysis of the feces showed that S. horneri stimulated the fecal excretion of triglyceride, as well as increased the fecal polysaccharide content. Furthermore, extracts of S. horneri inhibited the activity of pancreatic lipase in vitro. These results showed that S. horneri can ameliorate diet-induced metabolic diseases, and the effect may be partly associated with the suppression of intestinal fat absorption.

Effects of Rice with Different Amounts of Resistant Starch on Mice Fed a High-Fat Diet: Attenuation of Adipose Weight Gain.

Increasing the amount of resistant starch (RS) in the diet may confer protective effects against chronic diseases. Rice, a good dietary source of carbohydrates, also contains RS. However, it remains unclear if RS at the amount consumed in cooked rice has a health benefit. To address the question, we examined the effects of cooked rice containing different levels of RS in a diet-induced obesity rodent model. Rice containing RS as low as 1.07% attenuated adipose weight and adipocyte size gain, induced by a moderately high-fat (HF) diet, which correlated with lower leptin levels in plasma and adipose tissue. Rice with 8.61% RS increased fecal short-chain fatty acid levels, modulated HF-diet-induced adipose triacylglycerol metabolism and inflammation-related gene expression, and increased fecal triglyceride excretion. Hence, including rice with RS level at ≥1.07% may attenuate risks associated with the consumption of a moderately HF diet.

A novel gastrointestinal microbiome modulator from soy pods reduces absorption of dietary fat in mice.

Simplification of diets, low in variety but high in energy, contributes to the loss in diversity observed in the obese gastrointestinal (GI) microbiome. A novel GI microbiome modulator (GIMM) as a dietary intervention was developed. Mice were fed either an obesogenic diet (ObD) or an ObD containing 15% activated soy pod fiber (ObD-ASPF) for 30 days. The diets were isocaloric and balanced for macronutrient content. ASPF is a novel fiber preparation from whole soy pods that is activated to produce glyceollins. Mice fed ObD-ASPF did not gain body fat. This was associated with decreased absorption of calories (P < 0.05) and increased fecal excretion of triglycerides, which may be attributed to decreased bile acid secretion (P < 0.05). A shift (P < 0.05) in abundances of microbiota in 10 genera was observed. Mice fed ObD-ASPF had elevated plasma concentrations of the anti-inflammatory IL-10 (P < 0.05) and decreased (P < 0.05) plasma concentrations of the neutrophil chemoattractant CXCL1. A novel dietary intervention derived from soy pods that acts to hinder absorption of dietary fat and glucose in mice was developed. More studies with this GIMM in animal models of diet-induced nonalcoholic fatty liver diseases, type 2 diabetes, and autism are needed.

Microspheres as carriers for lipase inhibitory substances to reduce dietary triglyceride absorption in mice

The present study intends to use microspheres as a delivery system of chlorogenic acid (CGA) to investigate the influences of CGA microspheres on dietary fat absorption and fecal triglyceride excretion in a mice model. Microspheres have an average particle size of about 53.3 μm. Results indicated that the microspheres were capable of gradually releasing the preloaded CGA into the surrounding medium. Their bioadhesive property might help prolong the gastrointestinal transit time in mice, and render a better mixing and contact between CGA and triglyceride. Consumption of CGA microspheres resulted in a significantly higher level of fecal triglyceride (119–144%) as compared with the corresponding control groups. A microsphere would be a desirable vehicle for CGA to improve its efficacy along the intestine.

Anti-obesity and anti-insulin resistance effects of tomato vinegar beverage in diet-induced obese mice.

This study investigated the mechanism of processed tomato vinegar beverage (TVB)-mediated anti-obesity and anti-insulin resistance effects in high-fat diet (HF)-induced obese mice. Oral administration of TVB (14 mL kg(-1) body weight) to HF-fed mice for 6 weeks effectively reduced the body and visceral fat weight and significantly lowered plasma free fatty acid, triglyceride and hepatic triglyceride levels. TVB significantly increased fecal triglyceride excretion, both phosphorylated AMP-activated protein kinase (AMPK) and acetyl-CoA carboxylase (ACC) and peroxisome proliferator-activated receptor (PPAR)α protein levels in the liver, which were associated with increased fatty acid β-oxidation and carnitine palmitoyltransferase activities in HF-fed mice. TVB improved glucose tolerance, hyperinsulinemia and HOMA-IR levels in the HF + TVB group compared to the HF group. Additionally, TVB significantly increased glucokinase activity and decreased glucose-6-phosphatase activity in the liver, which enhanced glucose metabolism in obese mice. These results suggest that TVB prevents visceral obesity and insulin resistance via AMPK/PPARα-mediated fatty acid and glucose oxidation.

Anti-obesity activity of hen egg anti-lipase immunoglobulin yolk, a novel pancreatic lipase inhibitor

BackgroundThere is completely no report about both hen egg anti-lipase immunoglobulin yolk (IgY) and its anti-obesity action. Thus, we tried to isolate and characterize a novel anti-lipase immunoglobulin from hen egg yolk. Moreover, we investigated whether hen egg yolk anti-lipase IgY inhibits pancreatic lipase activity in vitro, and examined its ability to prevent obesity in a murine high fat diet-induced obesity model.MethodsWe determined the inhibitory action of Anti-lipase IgY on lipase activity in vitro. We also focused our evaluation on the anti-obesity properties of Anti-lipase IgY in a murine high fat diet-induced obesity model.ResultsAnti-lipase IgY blocked porcine lipase activity with an IC50 of 0.49 μM. Supplementing the high fat diet with only 0.2% (w/w) of Anti-lipase IgY for 35 days significantly decreased the weights of intraperitoneal adipose tissues, epididymal, mesenteric, retroperitoneal and perirenal adipose tissues, and the amounts of hepatic total lipid, triglyceride, and cholesterol. This was accompanied by a significant increase in the fecal excretion of triglyceride in the absence of diarrhea. Furthermore, Anti-lipase IgY treatment restored body weight gain to levels similar to mice fed with Control IgY.ConclusionsThis study provides the first report of the development of anti-lipase IgY and the direct evidence that inhibition of pancreatic lipase using Anti-lipase IgY is an effective anti-obesity treatment due to the associated increase in fecal excretion of triglyceride.

Effect of Cheonggukjang made with germinated soybean on lipid contents and fecal excretion of neutral steroids in rats fed a high cholesterol diet

This study was conducted to investigate the effect of cheonggukjang made with soybean germinated under dark and light conditions on lipid content and fecal neutral steroids in rats fed with a high cholesterol diet. Rats were divided into 4 groups: high cholesterol diet (HC); high cholesterol diet containing normal cheonggukjang (HNC); high cholesterol diet containing cheonggukjang made with soybean germinated under dark condition (HDC); high cholesterol diet containing cheonggukjang made with soybean germinated under light condition (HLC). Dietary supplementation with light-reacted cheonggukjang decreased hepatic triglycerides, compared with the other groups. Fecal excretion of total lipids and triglycerides increased when fed with cheonggukjang made with soybean germinated under light condition. Fecal excretion of coprostanol, cholesterol, and coprostanone tended to increase in the cheonggukjang-supplemented groups. These results suggest that dietary supplementation with cheonggukjang made with germinated soybean might prevent hyperlipidemia by improving the lipid metabolism through decreasing the liver triglycerides contents and increasing fecal excretion of triglycerides.

Potentiation of Hypolipidemic and Weight-Reducing Influence of Dietary Tender Cluster Bean (Cyamopsis tetragonoloba) When Combined with Capsaicin in High-Fat-Fed Rats

Soluble fiber-rich tender cluster bean pod (Cyamopsis tetragonoloba) (CB) and a combination of CB and capsaicin, a thermogenic spice compound, were evaluated for weight-reducing effect in high-fat-fed Wistar rats. Freeze-dried CB and capsaicin were included at 15 and 0.015%, respectively, in the high-fat (30%) diet for 8 weeks. Excretion of dietary fat, fat deposition in adipose, and activities of enzymes involved in lipolysis and lipogenesis were examined. CB and capsaicin additively decreased weight gain in high-fat-fed rats, without affecting feed intake. The antiobesity potential of CB was through impeding fat accumulation in adipose and enhancing fat excretion. Decrease in adipose triglyceride by the combination was higher than their individual effects and was accompanied by enhanced activity of hormone-sensitive lipase-facilitating mobilization of depot fat. Increased fecal excretion of triglycerides by the combination of CB and capsaicin was additive. Whereas the hypolipidemic effect of the combination was higher than their individual effects, the decrease in hepatic cholesterol and triglycerides produced by the combination was additve. Thus, dietary CB significantly checked weight gain and adverse changes in lipid profile in high-fat-fed condition amounting to a cardioprotective effect. These beneficial effects were potentiated by coadministration of capsaicin.

Anti-obesity Activity of Peucedanum Japonicum Thunb Extract in Obese Diabetic Animal Model C57BL/6J Ham Slc-ob/ob Mice

Aim of the study is to evaluate the anti-diabetic activity of PJT. This study examined its anti-obesity activity in obese-diabetic animal model of C57BL/6J Ham Slc-ob/ob mice. By dividing animals into control and ethanol extract of PJT groups, body weight gain, tissue weight, biochemical parameters in serum, liver, fecal lipid concentrations and gene expression in the tissues were compared between control and PJT extract groups after been fed with the basal low-fat diet supplemented with or without PJT extract for four weeks. The results show that supplementation of the diet with ethanol extract of PJT significantly reduced white adipose tissue (WAT), serum triglyceride (TG), total cholesterol (TC) and adipocyte size. The ethanol extracts also significantly increase insulin sensitivity, fecal excretion of TG, TC, and decreased that of bile acid. The ethanol extract of PJT modulated the obesity related genes in liver, adipose tissues of ob/ob mice: upregulation of PBEF1, PPARα, and downregulation of FAS genes in the liver; upregulation of RORC, DGAT1, FXRα, PPARγ genes in the adipose tissue; increased expression of CPT1α, UCP2 and GLUT4 genes in muscle. In conclusion, it is suggested that ethanol extract of PJT exerted anti-diabetic activity through the modulation of obesity-related lipid parameters in obese-diabetic animal model.

Comparative Study of the Hepatoprotective Efficacy of Artemisia iwayomogi and Artemisia capillaris on Ethanol‐Administered Mice

We compared the effects of ethylacetate extracts from Artemisia iwayomogi (AIE) and Artemisia capillaris (ACE) on ethanol-induced hepatic injury in mice. Ethanol (25% v/v, 5 g/kg body weight) was orally administered once a day for 6 wk. AIE or ACE was provided in the diet (0.05 g/100 g diet). AIE and ACE did not affect hepatic alcohol dehydrogenase activity but did significantly inhibit cytochrome P450 2E1 activity. Hepatic acetaldehyde dehydrogenase 2 activity significantly increased in the AIE group compared to the control group. AIE caused a significant decrease in plasma acetaldehyde levels and aspartate transaminase and lactate dehydrogenase activities, whereas ACE slightly decreased these values compared to the control. Hepatic catalase activity and glutathione levels were significantly increased by AIE and ACE supplements, whereas glutathione peroxidase activity was higher only in the AIE group compared to the control group. AIE and ACE supplements significantly lowered the plasma cholesterol concentration and increased the HDL-cholesterol/total cholesterol ratio compared to the control group. Compared to the control, both AIE and ACE groups showed a significant decrease in hepatic triglyceride levels and an increase in fecal triglyceride excretion simultaneous with inhibition hepatic activities of fatty acid synthase, phosphatidate phosphohyrolase, fatty acid β-oxidation, and carnitine palmitoyltransferase. AIE significantly lowered hepatic cholesterol levels and increased fecal cholesterol levels compared to the control. These results indicate that AIE and ACE exhibit hepatoprotective and hypolipidemic properties by enhancing hepatic alcohol, antioxidant, and lipid metabolism. AIE seemed to have more potent hepatoprotective effects than ACE.

갈대순분말이 고지방을 급여한 마우스의 지질대사 및 적혈구 항산화방어계에 미치는 영향

본 연구는 고지방을 급여한 마우스의 체내 지질개선 및 항산화 방어계에 미치는 갈대순의 영향을 구명하고자 하였다. 4주령의 ICR마우스(n=24)를 1주일간 적응시킨 후 정상식이를 급여한 정상군, 고지방을 급여한 고지방군, 고지방-갈대순분말 급여군으로 나누어 8주간 사육하였다. 갈대순분말은 사람이 하루에 3잔의 차를 마시는 양을 고려하여 식이에 1% 수준이 되도록 첨가?조제하여 급여하였다. 갈대순 분말군의 체중, 일일 식이섭취량과 에너지섭취량은 고지방군에 비하여 감소하는 경향이었다. 갈대순분말 급여 시 혈장의 총 콜레스테롤 함량은 고지방군에 비하여 19% 감소되었고 중성지질 함량은 36% 유의적인 감소를 보였다. 갈대순분말은 고지방식이로 축적된 간 조직의 중성지질 함량 변화에는 영향을 미치지 않았으나 콜레스테롤 함량은 고지방군에 비하여 유의적으로 낮추었다. 심장조직의 중성지질과 콜레스테롤 함량 역시 정상군에 비하여 고지방군이 각각 145%, 112%의 유의적인 증가를 나타내었으나 갈대순분말 급여로 중성지질 함량은 감소경향을 보였으며 콜레스테롤 함량은 정상군과 유사한 수준으로 개선되었다. 갈대순분말은 고지 방군에 비하여 분변으로의 중성지질과 콜레스테롤 배설을 각각 27%와 28% 유의적으로 증가시켰다. 갈대순분말은 간조직의 지방산 산화에는 영향을 미치지 않았고 지방산 합성 효소 활성을 유의적으로 억제하였다. 간 조직 중의 HMGCoA reductase와 ACAT 활성도 역시 갈대순급여군이 고지방군에 비하여 유의적으로 낮았다. 적혈구 중의 SOD와 CAT 활성은 정상군에 비하여 고지방식이 급여 시 유의적인 증가를 보였으나 GSH-Px 활성은 고지방식이로 인한 변화가 관찰되지 않았다. 반면, 갈대순분말 급여는 적혈구의 SOD와 CAT 활성과 지질과산화물 함량을 고지방군에 비하여 유의적으로 낮추었다. 이와 같이 갈대순분말은 고지방식 이를 급여한 마우스의 간 조직에서의 지방산과 콜레스테롤 합성을 저해하고 분변으로의 지질배설을 증가시킴으로써 혈장 지질개선에 효과적이었으며 적혈구의 항산화 효소활성도와 지질과산화물 함량도 개선하는 것으로 나타났다.

Dietary docosahexaenoic acid‐rich diacylglycerols ameliorate hepatic steatosis and alter hepatic gene expressions in C57BL/6J‐Lepob/ob mice

We examined the effect of docosahexaenoic acid (DHA)-enriched structured lipids-diacylglycerol (SL-DG), which were synthesized using soybean oil (SO) and algae oil (AO), on hepatic lipid metabolism and the mRNA expression of genes involved in hepatic steatosis of C57BL/6J-Lep(ob/ob) compared to the SL-triacylglycerol (TG). The animals were fed a high-fat (10% lard and 10% test oils) and high-cholesterol (0.2% cholesterol) diet for 12 weeks. Mice fed SL-DG showed a lower total white adipose tissue weight and plasma triglyceride concentration than the SO group. Reduction of hepatic triglyceride content in the SL-DG group was related with the suppression of hepatic enzyme activities for fatty acid and triglyceride synthesis along with fecal triglyceride excretion compared to the SL-TG. SL-DG also lowered hepatic cholesterol levels by suppressing cholesterol regulating enzyme activity compared to the SO group. Moreover, SL-DG lowered the mRNA expressions of sterol regulatory element binding protein-1 and its target genes than TG-form oils (SO, AO and SL-TG) in the liver. Thus, the current results suggest that DHA-enriched SL-DG oil used in this study is beneficial for ameliorating hepatic steatosis in obese animal model by improving hepatic fatty acid and cholesterol metabolic enzyme activity and their gene expression.

포도씨열수추출물이 고지방식이로 유도한 비만마우스의 지질대사와 적혈구 항산화 방어계에 미치는 영향

This study was investigate the effect of grape seed water extract (GSW) on lipid profiles, lipid metabolism and erythrocyte antioxidant defense system in high-fat diet-induced obese mice. Three groups of male C57BL/6 mice were fed different diets for 6 weeks: normal diet (Normal), high-fat diet (HF control; 37% calorie from fat) and high-fat diet supplemented with GSW (HF-GSW; 1% wt/wt). Supplementation of GSW did not affect the body weight, food intake, daily energy intake, white adipose tissue weights and plasma leptin level in high-fat fed mice. Plasma and hepatic cholesterol and triglyceride contents were significantly higher in the HF control group than in the Normal group; however, GSW supplement significantly lowered plasma triglyceride and hepatic cholesterol concentrations compared to the HF control group. GSW supplement significantly increased fecal excretion of triglyceride in high-fat fed mice. Hepatic carnitine palmitoyl transferase activity was significantly higher in the HF-GSW group than in the HF control group, while fatty acid -oxidation tended to be lowered by GSW supplement. Erythrocyte superoxide dismutase activity was also significantly higher in the HF-GSW group than in the HF control group and glutathione peroxidase activity tended to be lowered in HF-GSW group. The GSW supplement significantly lowered erythrocyte lipid peroxidation level compared to the HF control group. Accordingly, these results suggest that GSW can be considered as a lipid-lowering agent and as being effective for enhancing erythrocyte antioxidant defense system in high-fat diet-induced obese mice.

Lipid-Lowering Effect of Hot Water-Soluble Extracts ofSaururus chinensisBail on Rats Fed High Fat Diets

We evaluated the inhibition of low-density lipoprotein (LDL) oxidation inhibition by a hot water-soluble extract of Saururus chinensis Bail (HWSCB) in vitro and the lipid-lowering effects of HWSCB in rats fed high fat diet (HFD). HFDs were supplemented with 5% HWSCB (HFSCB5 group), 10% HWSCB (HFSCB10 group), or 1% tannic acid (Tannin group). The Tannin group served as a positive control for the study, based on tannic acid's known lipid-lowering effect and water-soluble characteristics. LDL oxidation was dose-dependently inhibited in the presence of HWSCB, and the effect of HWSCB was comparable to that of vitamin C. Significant reductions in triglyceride (P < .05) and cholesterol (P < .05) levels in the plasma and liver of the HFSCB5, HFSCB10, and Tannin groups were observed. High-density lipoprotein cholesterol was elevated (P < .05), but LDL was decreased in a dose-dependent manner for the HFSCB samples. These results were associated with a significant decrease in the atherogenic index for the HFSCB samples, especially for HFSCB10. In addition, fecal excretion of triglyceride with HWSCB supplementation was greater than with tannic acid supplementation. The findings of this study suggest that HWSCB may reduce plasma and hepatic lipids, especially triglyceride, in rats fed high fat diet.

Soybean beta-conglycinin diet suppresses serum triglyceride levels in normal and genetically obese mice by induction of beta-oxidation, downregulation of fatty acid synthase, and inhibition of triglyceride absorption.

The purpose of this study was to discover the effects of soybean beta-conglycinin (7S-globulin) and glycinin (11S-globulin) on serum lipid levels and metabolism in the livers of normal and genetically obese mice. Male normal (ICR) and obese (KK-Ay) mice were fed ad libitum high fat diets for two weeks, followed by a 2-week restriction of diet (2 g diet/mouse/day) containing 20% casein, soybean beta-conglycinin, or soybean glycinin, and then sacrificed immediately. Serum triglyceride (TG), glucose, and insulin levels of beta-conglycinin-fed mice were lower than in casein- and glycinin-fed mice of both strains. In order to analyze the related events to these effects, enzyme activities and relative mRNA levels of lipid metabolism-related proteins were measured. The activities of two enzymes related to fatty acid beta-oxidation were higher while that of fatty acid synthase was lower in livers of beta-conglycinin-fed mice than of casein-fed both mice. Messenger RNA levels of acyl-CoA oxidase (fatty acid beta-oxidation related enzyme) were significantly higher in livers of beta-conglycinin-fed mice than of both casein-fed mice. On the contrary, mRNA levels of SREBP-1 and 2 tended to be lowered in livers of soy protein-fed mice than of both casein-fed mice. Fecal excretion of TG was higher in beta-conglycinin-fed mice than in casein-fed mice. Our results demonstrated that the soy beta-conglycinin diet reduced serum TG levels by acceleration of beta-oxidation, suppression of fatty acid synthase and/or increased TG fecal excretion, and also diminished serum glucose and insulin levels. Some of these events might be caused at the transcriptional levels, judged from the result that relative messenger RNA levels of lipid metabolism-related proteins were altered. These results suggest that soy beta-conglycinin could be a potentially useful dietary protein source for the prevention of hypertriglyceridemia, hyperinsulinemia, and hyperglycemia, which are recognized as risk factors for atherosclerosis.

동충하초 균사체 액체배양액이 고지혈증 흰쥐의 지질대사 및 효소활성에 미치는 영향

동충하초(C. militaris)의 균사체 액체배양액이 고지방 식이를 섭취한 성숙한 암쥐의 생리활성에 미치는 영향을 평가하고자, 생후 30주령의 흰쥐에 표준식이를 급여한 정상군, 표준식이에 15% 돈지와 1% 콜레스테롤을 첨가한 식이를 급여한 고지방군, 고지방 식이에 균사체 액체배양액을 각각 10%, 20% 및 30%씩 음료수에 혼합하여 급여한 군 등 5군으로 나누어 5주간 사육하였다. 실험동물의 체중증가, 식이효율, 및 간의 무게는 고지방군과 각 수준별 균사체 배양액군이 비슷한 수준을 보였으나 정상군 보다는 유의하게 증가되었다. 간의 총 지질 농도, 간과 혈청의 중성지질 농도 및 동맥경화지수는 고지방군에 비하여 20%와 30% 균사체 배양액군이 유의하게 감소시키는 효과가 나타났다. 혈청의 HDL-콜레스테롤 농도는 고지방군에 비하여 각 수준별 균사체 배양액군이 유의하게 증가시키는 효과가 나타났다. 분중 중성지질 배설량은 고지방군에 비하여 20%와 30% 균사체 배양액군이 유의하게 증가되었다. 간과 혈청의 총 콜레스테롤 농도, 혈청의 LDL-콜레스테롤 농도, 분의 콜레스테롤 배설량, 및 혈청의 GPT와 ALP의 활성은 고지방군과 각 수준별 균사체 배양액군이 비슷한 경향으로 나타났으나 정상군 보다는 유의하게 증가되었다. 총 콜레스테롤에 대한 HDL-콜레스테롤 비율은 정상군에 비하여 각 실험군이 유의하게 감소되었다. 혈당, 혈청의 총 단백질과 알부민 농도, 알부민/글로불린 비율, 신장과 대퇴골의 무게, 혈청의 COT와 <TEX>${\gamma}$</TEX>-CTP의 활성은 정상군과 각 실험군이 비슷하여 정상 수준을 유지하였다. 이상의 결과로 보아 고지방 식이에 20% 및 30% 동충하초의 균사체 액체배양액 섭취가 간의 총 지질, 간과 혈청의 중성지질 농도 및 동맥경화지수를 낮추는 효과가 있고, HDL- 콜레스테롤 농도를 증가시키는 효과가 있는 것으로 나타났다.각된다. The effect of liquid cultures of Cordyceps militaris (LCM) on weight gain, food intakes, food efficiency ratios, serum and hepatic lipids, fecal lipids excretion, serum protein and enzyme activities, were investigated in adult female rats (30 weeks old). Sprague-Dawley rats were assigned to one normal and four hyperlipidemic diet groups, Hyperlipidemic diet groups (20% fat, 1% cholesterol) were divided into high fat diet (LCM free water), 10%, 20% or 30% LCM diet groups (10%, 20% or 30% LCM in water) according to the levels of LCM supplementation. After 35 days of experimental diet consumption, the body weight gains, hepatic weights, and food efficiency ratios of the rats fed hyperlipidemic diets were significantly increased compared with those of the rats fed normal diet. The concentrations of serum and hepatic triglycerides, hepatic total lipid, and atherogenic index of the rats fed 20% or 30% LCM diets were significantly lower than those of the rats fed the high fat diet. The concentration of serum HDL-cholesterol of the rats fed all LCM diets was significantly higher than those of the rats fed the high fat diet. The fecal excretion of triglyceride in the rats fed 20% or 30% LCM diets was significantly higher than those of the rats fed high fat diet. The concentrations of serum and hepatic total cholesterol, serum LDL-cholesterol, and HDL-cholesterol/total cholesterol ratio, fecal excretion of cholesterol, and the activities of serum glutamic pyruvic transaminase and alkaline phosphatase of the rats fed all LCM diets were similar to those of the rats fed high fat diet. No differences were noted in the weights of kidney and femur, the serum concentration of glucose, total protein and albumin, and the activities of glutamic oxaloacetic transaminase and <TEX>${\gamma}$</TEX> -glutamyltranspeptidase, among the rats on all the experimental diets. These results showed that the 20% or 30% LCM diets feeding decreased the serum and hepatic triglycerides, and the atherogenic index, and increased the serum HDL-cholesterol of the adult female rats.

Fecal triglyceride excretion is not excessive in pancreatic insufficiency

Steatorrhea can result from maldigestion or malabsorption. As the pathophysiology underlying impaired digestion differs from impaired absorption, it is important to differentiate these two disorders. It is generally accepted that patients with maldigestion excrete an excessive amount of triglyceride and patients with malabsorption excrete an excess of the lipolytic product of triglyceride, fatty acid. The two-step Sudan stain has been used as a simple test to differentiate these disorders. The validity of the test has not yet been established. In this study, fecal fatty acid and triglyceride were measured after extraction and thin-layer chromatographic separation. Our results indicate that in adult patients with pancreatic insufficiency, the fecal triglyceride content does not differ from the controls. However, a fivefold to sixfold increase in fecal fatty acid content in patients with pancreatic insufficiency was revealed. As patients with maldigestion do not excrete an excess of undigested triglyceride, it is not possible to differentiate maldigestion from malabsorption by quantifying fecal triglyceride and fatty acid.